Clinical Trial

Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations

Name: Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations — clinical trial record (NCT06673290)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to compare the efficacy and safety of different concentration gradients of sirolimus in the treatment of cystic lymphatic malformation.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-10-31; most recent amendment 2024-12-27.

Trial Details

NCT Number	NCT06673290
Lead Sponsor	West China Hospital
Conditions	Lymphatic Malformation
Enrollment	150 participants
Start Date	2024-11-30
Primary Completion	2026-12-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2024-12-31